TheProfitWatch

INMB - INmune Bio Inc. Common stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.49 0.01 (1.01%) --- 0.0 (0.0%) 0.0 (0.0%) 0.02 (1.34%) -0.01 (-0.33%) 0.02 (1.33%) 0.01 (0.67%)

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.05
Diluted EPS:
-1.05
Basic P/E:
-1.4333
Diluted P/E:
-1.4333
RSI(14) 1m:
40.0
VWAP:
1.51
RVol:

Events

Period Kind Movement Occurred At

Related News